Innovent Biologics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 10,614,500 | 0.652% |
VC/PE Firms | 89,475,350 | 5.5% |
Individual Insiders | 113,380,716 | 6.97% |
General Public | 676,047,476 | 41.5% |
Institutions | 737,583,759 | 45.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
114,164,873 | US$604.8m | 16.1% | 0.03% | |||
109,245,165 | US$578.8m | 0.34% | no data | |||
89,475,350 | US$474.0m | 0% | 29.72% | |||
57,852,349 | US$306.5m | 1.17% | no data | |||
55,364,540 | US$293.3m | 0% | 45.1% | |||
42,165,960 | US$223.4m | 17.9% | no data | |||
36,535,000 | US$193.6m | 0% | 0.19% | |||
33,453,000 | US$177.2m | 0% | 0.25% | |||
30,112,499 | US$159.5m | -0.09% | 0.07% | |||
27,097,655 | US$143.6m | 0% | 0.33% | |||
27,004,000 | US$143.1m | 0% | 0.09% | |||
25,928,788 | US$137.4m | 30.9% | 0.39% | |||
24,932,063 | US$132.1m | 0% | 0.12% | |||
24,023,500 | US$127.3m | 39.6% | 0.64% | |||
20,891,221 | US$110.7m | 10.6% | 0.01% | |||
14,999,175 | US$79.5m | -20.8% | 0.01% | |||
14,276,500 | US$75.6m | 0% | 71.3% | |||
10,165,139 | US$53.9m | -2.3% | 0.07% | |||
9,115,794 | US$48.3m | 44,700% | 0.03% | |||
8,747,500 | US$46.3m | 0% | 0.03% | |||
8,351,678 | US$44.2m | 76.8% | 0.02% | |||
8,191,500 | US$43.4m | -0.84% | 0.01% | |||
7,655,875 | US$40.6m | 0% | 0.17% | |||
7,531,000 | US$39.9m | 28.3% | 0.13% | |||
7,345,000 | US$38.9m | 0% | no data |